Lymph Node Analysis Could Improve Melanoma Treatment Options
Studies are demonstrating the potential of the Parsortix system to enhance laboratory efficiency, reduce costs, support medical decisionmaking, and improve patient care.
Read MorePosted by Chaunie Brusie | Mar 4, 2019 | Melanoma, Research |
Studies are demonstrating the potential of the Parsortix system to enhance laboratory efficiency, reduce costs, support medical decisionmaking, and improve patient care.
Read MorePosted by Steve Halasey | Jan 17, 2019 | Lung Cancer |
If approved, the test could be the first FDA-approved multigene sequencing-based in vitro diagnostic to accept both plasma and FFPE-based inputs.
Read MorePosted by Steve Halasey | Nov 12, 2018 | Cancer, Disease States, Lung Cancer, Molecular Diagnostics |
Droplet digital PCR is rapidly becoming an invaluable tool in cancer treatment research.
Read MorePosted by Steve Halasey | Nov 9, 2018 | Disease States, Leukemia, Lymphoma, Molecular Diagnostics |
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read MorePosted by Steve Halasey | Oct 31, 2018 | Digital Pathology |
Advanced tools and new analytical approaches promise to alter the shape of diagnostic medicine forever.
Read More